Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oncogenic Osteomalacia”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableLooking for participantsNCT07366099
What this trial is testing

Al18F-NOTA-LM3 PET/CT in Patients With TIO

Who this might be right for
Tumor-Induced Osteomalacia
Peking Union Medical College Hospital 40
Very early researchUnknownNCT01524016
What this trial is testing

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Who this might be right for
Oncogenic OsteomalaciaMesenchymal Tumor
Peking Union Medical College Hospital 100
Not applicableUnknownNCT02331966
What this trial is testing

Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia

Who this might be right for
Tumor Induced Oncogenic Osteomalacia
AHEPA University Hospital 10
Post-approval studies (Phase 4)Study completedNCT05357573
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Who this might be right for
Tumor-Induced Osteomalacia (TIO)
Kyowa Kirin Co., Ltd. 9
Early research (Phase 1)Ended earlyNCT01748812
What this trial is testing

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Who this might be right for
Osteomalacia
National Institute of Dental and Craniofacial Research (NIDCR) 1
Not applicableAvailableNCT03775187
What this trial is testing

Expanded Access to Burosumab

Who this might be right for
X-linked HypophosphatemiaTumor-Induced Osteomalacia
Kyowa Kirin Co., Ltd.
Testing effectiveness (Phase 2)Ended earlyNCT03510455
What this trial is testing

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

Who this might be right for
Tumor-Induced OsteomalaciaOncogenic Osteomalacia
National Institute of Dental and Craniofacial Research (NIDCR) 4
Not applicableActive Not RecruitingNCT04783428
What this trial is testing

Tumor-induced Osteomalacia Disease Monitoring Program

Who this might be right for
Tumor-induced Osteomalacia (TIO)
Ultragenyx Pharmaceutical Inc 23
Not applicableStudy completedNCT00099762
What this trial is testing

Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia

Who this might be right for
OsteomalaciaNeoplasms
National Institute of Dental and Craniofacial Research (NIDCR) 45
Testing effectiveness (Phase 2)Study completedNCT03736564
What this trial is testing

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Who this might be right for
Osteomalacia
Mayo Clinic 18
Not applicableUnknownNCT01660308
What this trial is testing

Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia

Who this might be right for
Hypophosphatemia
National Taiwan University Hospital 40
Not applicableUnknownNCT04045834
What this trial is testing

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Who this might be right for
PET / CTPET / MRNeuroendocrine Tumors+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT02304367
What this trial is testing

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Who this might be right for
Tumor Induced Osteomalacia (TIO)Epidermal Nevus Syndrome (ENS)
Kyowa Kirin, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02722798
What this trial is testing

KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

Who this might be right for
Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Kyowa Kirin Co., Ltd. 14
Early research (Phase 1)UnknownNCT04689893
What this trial is testing

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Who this might be right for
Tumor-Induced Osteomalacia
Peking Union Medical College Hospital 50